Submit Deal

Announced

17 Mar 2020

AGC to acquire Molmed for $267m.

Synopsis

AGC, a global contract development and manufacturing organization, offered to acquire Molmed, a biotechnology company, for $267m. AGC offered $0.577 per Molmed share, the equivalent of a premium of 110.3% compared to the stock’s closing price on March 16.

Principals

target

MOLMED

bidder

Agc

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (7)

riccardo palmisano

CEO at MOLMED

Manager

target

Deal

£ 217 M

Total Value

salvatore calabrese

CFO at MOLMED

Manager

target

Deal

£ 217 M

Total Value

carlo incerti

Chairman at MOLMED

Manager

target

Deal

£ 217 M

Total Value

auro palomba

Founder and CEO at Community Group

PR Consultant

target

343

Deals

£ 300.24 B

Total Value

nicola brunetti

Partner at Gattai Minoli Agostinelli & Partners

Lawyer

target

Deals

£ 11.29 B

Total Value

enrico candotti

Associate at Gattai Minoli Agostinelli & Partners

Lawyer

target

Deals

£ 245 M

Total Value

giuliano pasini

Partner at Community Group

PR Consultant

target

115

Deals

£ 14.84 B

Total Value

Bidder Team (3)

takuya shimamura

CEO at AGC INC

Manager

bidder

Deal

£ 217 M

Total Value

fabrizio ciglise

PricewaterhouseCoopers

Accountant

bidder

Deal

£ 217 M

Total Value

massimo benedetti

Partner at PricewaterhouseCoopers

Accountant

bidder

Deals

£ 1.35 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy